Cite
HARVARD Citation
Kim, E. et al. (2022). A GLP‐1/GLP‐2 receptor dual agonist to treat NASH: Targeting the gut‐liver axis and microbiome. Hepatology. 75 (6), pp. 1523-1538. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Kim, E. et al. (2022). A GLP‐1/GLP‐2 receptor dual agonist to treat NASH: Targeting the gut‐liver axis and microbiome. Hepatology. 75 (6), pp. 1523-1538. [Online].